Whitepaper: Cubis® II Pharma Compliant by Design
Sartorius’ Cubis® II balance series offers customisable modularity to ensure compliance with FDA directive 21 CFR Part II and EU Annex 11. This whitepaper outlines details of the technical solutions that will enable companies to achieve full compliance.
The Cubis® II balance series was designed for customisable modularity, which means the user can choose from many hardware and software options for thousands of different configurations. Choose from among 45 weighing modules, seven draft shields, two display and control units, and five software packages, including more than 60 software apps.
Related content from this organisation
- Bioprocessing & Bioproduction In-Depth Focus 2019
- Sartorius Stedim Biotech – offering innovative single-use technologies for advanced bioprocessing
- Guide to Single-Use
- Application note: Cell-Based Therapies – Be on the Safe Side
- Whitepaper: Impact of the Claristep® Filtration System on recovery and adsorption of various therapeutic proteins at low sample volumes